Skip to main content

Table 3 Survival status of the groups

From: Levosimendan may improve survival in patients requiring mechanical assist devices for post-cardiotomy heart failure

 

Conventional

Levosimendan

P value

n

29

9

 

AD survival

20

9

p = 0.082

ICU survival

9

8

p = 0.005

Hosp survival

7

8

p = 0.001

180-day survival

3

7

p < 0.001

  1. Chi square test was used and p values between the groups were determined according to exact Fischer's test. 180-day survival, survival of the first 180 days after surgery; AD survival, survival of assist device; Hosp survival, survival of hospital stay; ICU survival, survival of intensive care unit stay.
Back to article page

Critical Care

ISSN: 1364-8535